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Alpha-bungarotoxin  (a-BuTX) had been found to 
block neuromuscular  transmission by an antidepo- 
larizing action (6). It has been suggested that a- 
BuTX binds irreversibly and with high specificity 
to the nicotinic-acetylcholine  receptor of the post- 
synaptic membrane (6, 17), and that d-tubocurar- 
ine protects these receptors from the toxin (7, 19). 
These conclusions have been substantiated by the 
autoradiographic  findings that,  in  mice,  lz~I-la- 
beled a-BuTX accumulates within the motor end- 
plate  region of various muscles (11,  17)  in the 
same manner as radioactive curare (27). Here, we 
report the presence, in vivo, utilizing light micro- 
scope  autoradiography,  of  a  similar type  of  a- 
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of the rat brain. 
MATERIALS  AND  METHODS 
a-Bungarotoxin was isolated from the lyophilized venom 
of Bungarus rnulticinctus (Miami Serpentarium Labora- 
tories, Miami, Fla. and Sigma Chemical Company, St. 
Louis, Mo.) by a modification of the method of Lee et al. 
(18). The venom was first chromatographed on washed 
CM-Sephadex C-50,  and  fraction II (18)  was  isolated 
and  further  purified  by  CM-cellulose chromatography 
(18). Although Lee et al. (18) used 0.05  M NH4OAc, 
pH 5.0, to elute two protein fractions, this buffer did not 
elute  our  fraction  II  from  the  CM-cellulose and  the 
buffer concentration was increased to 0.1  M NH4OAc, 
pH 6.0, which then resolved fraction II into two protein 
fractions.  The  second  fraction  (II-B) contained  about 
70%  of the  protein  applied  to  the  column  and  was 
lyophilized  and  desalted  on  Sephadex  G-25  column 
equilibrated with 0.05 M NaH2PO4, pH 7.5.5/zg/ml of 
fraction II-B reduced in vitro isometric contraction of the 
rat diaphragm  (30-s  interval stimulation of the phrenic 
nerve)  to  half-strength  in  18-19  min  and  completely 
blocked contraction in about 30 rain. These results indi- 
cate that fraction II-B had the properties of a-BuTX (6). 
Protein concentration was determined by optical density 
at 260 and 280 nm. Fraction II-B (25, 50, and 100  ttg) 
was analyzed by disc electrophoresis (15 % cross linking; 
stacked at pH 5.0, and run at pH 4.3,  [alanine-acetate 
buffer])  and  only  one  protein  staining  band  was  ob- 
served. 
[3H]a-Bungarotoxin  ([3H]a-BuTX) was  prepared by 
the  acetamidination  method  of  Zull  and  Repke  (30) 
for  the  preparation  of  tritiated  polypeptides.  The 
[3H]acetamidino-a-bungarotoxin  ([3H]a-BuTX)  (sp  act 
~1.5  /zCi//~g) was  separated  from unreacted  [methyl- 
3H]acetimidate  hydrochloride by gel filtration on Sepha- 
dex G-25. The  [aH]a-BuTX appeared  radiochemically 
pure as indicated by disc electrophoresis (Fig. 1), and the 
[3H]ct-BuTX had  the same electrophoretic mobility as 
the a-BuTX before acetamidination. In the rat phrenic 
nerve-diaphragm  preparation,  the  [3H]a-BuTX  in- 
hibited  indirect-stimulated  muscle  contraction  in  the 
same time as the radioinert oe-BuTX. Both [3H]a-BuTX 
and  a-BuTX were stored at  -15~  in 0.05  M NaPO4 
buffer, pH 7.5. 
Since  a-BuTX does not readily pass the blood-brain 
barrier (17) and since our studies  are primarily directed 
toward the hypothalamus, the [3H]a-BuTX was injected 
intracranially.  Female Holtzman rats (250-300 g) were 
placed in a stereotaxic instrument under ether anesthe- 
sia. With the use of bregma coordinates of Pellegrino and 
Cushman  (21),  0.8  mm anterior,  7.5-8.0  mm ventral, 
and 0.0 mm lateral, a fine glass cannula was inserted into 
the third ventricle of the diencephaion in a region of the 
preoptic nuclei, and one of the following solutions was 
infused:  (a) 7.0/zg of [3H]a,-BuTX (8.75  x  10 -3 M) in 
10.0 ktl of (0.05 M; pH 7.4) NaH2PO4 buffer; (b) to test 
for possible  nicotinic specificity of toxin binding, 7.0 ~g 
of d-tubocurarine chloride (1.0 x  10 -2 M) in 10.0 ~1 of 
buffer followed 30 min later by the same solution as in 
(a); (c) to test for possible  muscarinic  specificity of toxin 
binding, 3.5/,Lg of atropine sulfate  (1.0  x  10 -2 M atro- 
pine) in 10.0 ~tl of buffer followed 30 rain  later by the 
same solution as in (a); (d) to test for nonspecific bind- 
ing, uptake, or retrograde transport within cells,  1.6/~g 
of  [3H]parathyroid  hormone  ([3H]PTH)  (31)  (2.0  x 
10 -3 M; 1.0 ~tCi/~g) in 20.0 ~1 of (50.0 raM; pH 7.0) 
HOAC buffer; (e) to test for positive chemography (8), 
the same concentration as in (a) of radioinert a-BuTX 
(but no  [3H]a-BuTX) in  10.0  /~1 of sodium phosphate 
buffer. The cannula  remained in place throughout the 
combined infusions  in series (b)  and  (c).  The various 
solutions  were infused  manually at an approximate rate 
of 1.0/~l/min. The injections of a-BuTX did not cause 
any overt symptoms. 
The animals  were anesthetized with ether and sacri- 
riced 2, 12, or 24 h after injection by perfusion through 
the heart with, first,  10-20 ml of 0.9% saline  and then 
400  ml  of  10%  Formalin-0.9%  saline  fixative,  both 
37.0~  The brains were placed in saline-Formalin solu- 
tion for 1 wk and then processed routinely for paraffin 
embedding.  Coronal  sections  were  cut  at  13  ~tm, 
mounted on glass slides, deparaffinized, and coated with 
Kodak NTB-2 nuclear tract, autoradiographic emulsion. 
The coated slides were stored in a light-proof container 
at 4~  for 4 wk, and then processed photographically, 
cover slipped,  and  examined under the phase  contrast 
microscope. 
RESULTS 
[3H] c~-Bu  TX 
2  h  after  stereotaxic  infusion  of  [3H]a-BuTX 
into  the  third  ventricle  (two  animals),  label  was 
dispersed throughout the entire brain.  Grain den- 
sity was highest over brain tissue immediately sur- 
rounding the third ventricle and especially around 
the  endothelium  of  blood  vessels.  Proceeding 
radially from the ventricle along its entire length, 
levels of grain  density  were  progressively dimin- 
ished.  High  concentrations  of label  were  found 
overlying  the  upper  portion  of  the  ependymal 
zone  which  lines the third  ventricle. In addition, 
a  few  isolated  loci  of  dense  label  accumulation 
were  scattered  over  the  arcuate  region  of  the 
hypothalamus. 
12  h  (two  animals)  and  24  h  (three  animals) 
after  injection  of  [3H]a-BuTX,  the  intensity  of 
label overlying the  greater  part  of the  brain  and 
around  vascular  endothelium  was  greatly  de- 
creased. No striking difference in labeling pattern 
was observed between the 12-h and 24-h animals. 
In several discrete areas the density of labeling was 
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standing of these  zones  appeared as a  series of 
contiguous clusters of intense radioactive label ex- 
tending throughout the mediobasal region of the 
hypothalamus  and  the  central  nucleus  of  the 
amygdala. Thus, proceeding mediolaterally, accu- 
mulations  of label  were  seen  overlying (a)  the 
ependymal zone on either side of the third ventri- 
cle,  directly opposite  and  slightly dorsal  to  the 
medial boundary of the arcuate nucleus (Fig. 2), 
(b) the arcuate nucleus (Fig. 2),  (c) the base of 
the tuber cinereum (Fig. 2),  (d) the ventralmost 
aspect of the lateral hypothalamic area but imme- 
diately dorsal to the optic tract, (e) the supraoptic 
nucleus (Fig. 5),  and (f) the central amygdaloid 
nucleus.  In  one  animal  at  24  h  label  was  also 
present  over the  medial nuclei of the  amygdala 
and habenula. 
More rostrally, below the third ventricle, label 
appeared in the midline and was continuous with 
that  spreading bilaterally along  the  base  of the 
brain towards the supraoptic nuclei. Further for- 
ward,  but  continuous  with  more  caudal  labeled 
regions, the preoptic suprachiasmatic (Fig. 3) and 
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FIGURE 1  Disc electrophoresis  of [aH]acetamidino-a- 
bungarotoxin (869,000  cpm). The dark band at the top 
of the figure represents the location of the single protein- 
staining band. l-ram thick slices were taken for quantifi- 
cation in a liquid scintillation spectrometer. 
suprachiasmatic  nuclei  (Fig.  4)  were  heavily 
labeled.  These  dense  labeling  patterns  were 
bilateral in all instances. In addition, throughout 
the uppermost wall and roof of the third ventricle, 
silver grains were concentrated over the internal 
glial cell layer of the ependymal region. 
d- Tubocurarine Pretreatment Followed 
by [aH]a-BuTX 
2 h (one animal), 12 h (two animals), and 24 h 
(one animal) after the combined administration of 
first tubocurarine and then  [3H]a-BuTX, the pat- 
tern  of diffuse  labeling overlying the  brain  was 
similar to that after the injection of [aH]a-BuTX 
alone (compare Fig. 63 and b). However, intense 
label accumulations over the central amygdaloid 
nucleus,  basolateral  hypothalamus,  arcuate  re- 
gion,  and  supraoptic and  suprachiasmatic nuclei 
were lacking. Label was still present at the upper 
ependymal zone  of the  third ventricle, but  was 
diminished over the lower ependyma rostral and 
adjacent to the arcuate nucleus (compare Fig. 6 a- 
c). 
Atropine  Pretreatment Followed 
by pH]a-BuTX 
12 h (two animals) after the combined injection 
of first atropine and then  [ZH]a-BuTX, the  pat- 
tern of labeling over the brain was comparable to 
that  seen  12  h  after injection with  [3H]a-BuTX 
alone (Fig. 63). 
[3H]PTH 
2,  12,  and 24 h  (one animal per time period) 
after the injection of [3H]PTH, the general distri- 
bution of diffuse label over the brain was similar to 
that seen after injection of [3H]a-BuTX (Fig. 6c). 
At each time, PTH label was also present over the 
ependymal and adjacent glial layer of the roof and 
upper section of the  third ventricle and  around 
blood vessels. However, the heavily labeled areas 
of the lower ependymal region of the third ventri- 
FmuaE  2  Light micrograph  (unstained  preparation) showing the distribution  of [3H]a-BuTX labeling 
over the basolateral  hypothalamus  and lower ependymal zone of the third ventricle (V) (indicated  by 
arrow). LHA, lateral hypothalamic area; M, median eminence; A, arcuate nucleus. (24 h). (￿  100). 
FIGURE  3  [aH]a-BuTX labeling (2,1 h) over the preoptic suprachiasmatic nucleus (PSCN). V, ventricle. 
(x 300). 
FmuaE  4  [3H]t~-BuTX  labeling (24 h) over the suprachiasmatic nuclei (SCN). V, ventricle. (x 200). 
958  BmEF  NOTES BRIEF NOTES  959 FIGURE 5  Light micrograph of the supraoptic nucleus 
(24 h) showing BuTX labeling (arrows). OT, optic tract. 
(x 40O). 
cle,  mediobasal,  and  basolateral  hypothalamus, 
and central amygdaloid nucleus were absent. 
NaH~P02 Buffer  +  t~-BuTX (Radioinert) 
12 and 24 h (one animal per time period) after 
the injection of radioinert a-BuTX in buffer solu- 
tion, the grain densities overlying the entire brain 
were at background levels. 
DISCUSSION 
Taken  together,  the  various patterns  of labeling 
with [3H]a-BuTX alone and with competitors sug- 
gest the presence of a discrete and pharmacologi- 
cally  specific  population  of  nicotinic-cholinergic 
neurons  within  the  mediobasal  and  basolateral 
portions of the hypothalamus, and the central nu- 
cleus of the amygdala. Whether labeling in these 
regions is  indicative  of a  pathway coursing hori- 
zontally between the arcuate region and the amyg- 
dala  is  unknown.  However,  a  bundle  of  such 
course has been demonstrated by the use of vari- 
OUS classical anatomical techniques (25). Although 
the chemical nature of the 3H or the concentrating 
mechanism in the  hypothalamus is not presently 
known,  t~-BuTX  is  believed  to  bind  specifically 
and essentially  irreversibly  to the  cholinergic re- 
ceptor at the  end-plate  region of the  diaphragm 
muscle.  Radioactive bungarotoxin,  however, has 
also been demonstrated to be associated with non- 
end-plate elements of the diaphragm in vitro (23), 
but this appears to be related to the concentration 
of  t~-BuTX  present  in  the  incubation  medium. 
After in vivo injection, however, most of the neu- 
rotoxin was associated with the end-plate  region 
(23), In the present studies  [3H]PTH, a polypep- 
tide with a molecular weight and a basic and acidic 
amino acid composition similar to that of [3H]a- 
BuTX,  did  not  result  in  intense  labeling  as  ob- 
served with [3H]ct-BuTX. Also, tubocurarine, but 
not atropine, reduced  [3H]a-BuTX accumulation 
within  the  mediobasal  hypothalamus and central 
amygdaloid nucleus, whereas neither drug had an 
appreciable  effect on toxin labeling elsewhere  in 
the brain. These data suggest the possibility that 
c~-BuTX labeling over hypothalamic and amygda- 
lar tissue may represent binding with high specific- 
ity to cholinergic membrane receptors, rather than 
nonspecific  or  possible  axonal  membrane  (10) 
binding  or  general  uptake  within  neurons.  The 
retention of the labeling pattern for 24 h supports 
this suggestion.  Other areas of dense  label accu- 
mulation, such as the ependymal roof of the third 
ventricle  and  the  endothelium  of blood  vessels, 
may represent sites of nonspecific toxin accumula- 
tion related to cerebrospinal fluid or blood-brain 
barriers (Fig. 6a-c) (4,  14). 
Although in vivo and in vitro analyses of brain 
-preparations  with  the  use  of  c~-neurotoxins  and 
various other techniques have suggested the exist- 
ence of cholinergic neuronal elements within and 
also distant from the hypothalamus and amygdala 
(1,9, 10, 15, 16, 22, 24, 28), in the present study 
the  limited  diffusion  of  [3H]a-BuTX  from  the 
third ventricle may prevent (or delay in animals at 
2  h  post-injection)  autoradiographic  labeling  of 
peripherally  located  areas.  Furthermore,  recent 
studies on nerve-muscle systems have shown that 
the  association,  as well  as the  dissociation, reac- 
tions between u-bungarQtoxin and "high affinity" 
ACh receptor sites  may occur slowly (over many 
minutes  or  hours)  (5,  12).  If present  centrally, 
comparably slow  binding  phenomena  could  also 
influence  the temporal pattern  of a-BuTX label- 
ing.  Other  sites  and  methods  of toxin  injection 
960  BvaEr  NOTES FIGURE 6  (a) Dark-field photomicrograph of the arcuate region of the hypothalamus in an animal which 
was injected with atropine and then 30 min later with [aH]a-BuTX and sacrificed after 12 h. Note: (i) the 
persistence of heavy labeling over the arcuate region (A) and the adjacent portion of the lower ependymal 
wall, and (ii) the heavy labeling over the upper wall of the third ventricle (arrow). V, ventricle. (x  100). 
(b) Dark-field photomicrograph of the arcuate region of the hypothalamus in an animal which was injected 
with tubocurarine and then 30 min later with [aH]a-BuTX and sacrificed after 12 h. Note: (i) the absence 
of heavy labeling over the arcuate region and nearby ependyma; and (ii) the presence of labeling over the 
upper ependymal zone (arrow). V, ventricle. (x  100).  (c) Dark-field photomicrograph of the arcuate 
region of the hypothalamus in an animal which was injected with [aH]PTH alone and then sacrificed after 
12 h. Note: (i) the absence of intense labeling over the arcuate region; and (ii) the accumulation of label 
over the roof of the third ventricle (arrow). Labeling of blood vessel endothelium is readily apparent in this 
section  (e.g., above asterisk).  V, ventricle. (x  100). 
may serve to elaborate additional cholinergic cen- 
ters.  In this  regard  Polz-Tejera et  al.  (22)  have 
recently  studied  the  in  vitro  binding of  125I-a- 
BuTX in the central nervous system of the rat by 
light  microscope  autoradiography  and  reported 
heavy labeling in the supraoptic nucleus and also 
the hippocampus. In that note (22), the presence 
or absence of labeling in other areas of the hypo- 
thalamus was not discussed. 
A  large  portion  of  the  a-BuTX  label  in  the 
hypothalamus  may  overlie  an  anatomically and 
functionally  well-defined  neurosecretory  region 
within the  so-called "hypophysiotrophic area"  of 
the diencephalon (13). This region, anatomically 
defined as a  portion of the mediobasal hypothai- 
amus immediately caudal to the preoptic area and 
rostral to the mammillary bodies, can maintain a 
pulsatile rhythm of high circulating concentrations 
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total  afferent  input  (2,  13).  It  is  premature  to 
tell  whether  synapses  involved in  the  release  of 
neurohormones  have  been  labeled  by  [aH]a- 
BuTX. 
The a-BuTX labeling over the lower portion of 
the third ventricle may be of nerve cell processes 
rather  than  of  ependymal  cells.  The  differential 
effect  of d-tubocurarine  (but  not  atropine)  pre- 
treatment on the pattern  of labeling over the up- 
per and lower walls of the third ventricle, and the 
contrast  of labeling  between  these  two  zones  in 
[sH]PTH-injected  animals,  support  this  hypothe- 
sis  (Fig.  6a-c).  The  position  of  labeling  at  the 
lower portion  coincides with  a  region of contact 
between the third ventricle and a system of infun- 
dibular- cerebrospinal fluid - contacting (I- CSF) 
neurons (26). It has been suggested that, via the I- 
CSF neurons,  luteinizing hormone-releasing hor- 
mone and other products may be released directly 
into  the  third  ventricle  and  thereby  transported 
within  the  CSF to  the  median  eminence,  where 
substances may be resorbed by tanycyte processes 
(3,  20, 26, 29).  It is noteworthy that the median 
eminence, the primary site of the ependymal tany- 
cytes, remained largely free of a-BuTX label. 
SUMMARY 
Purified  c~-bungarotoxin was isolated by chroma- 
tography  and  made  radioactive  with  tritium 
([aH]acetamidino-a-bungarotoxin).  Infusions  of 
[ZH]a-bungarotoxin  alone or preceded by tubocu- 
rarine or atropine were given into the third ventri- 
cle. 2,  12 or 24 h  after injection the brains were 
prepared  for  autoradiography.  Injections  of  a- 
bungarotoxin  (radioinert)  in  buffer,  or  of 
[SH]parathyroid hormone in buffer, served as con- 
trois. The various patterns of labeling suggest the 
presence  of  nicotinic-cholinergic  neurons  within 
the  arcuate  and  basolateral  regions of the  hypo- 
thalamus including the supraoptic and suprachias- 
matic nuclei and,  in addition, the central nucleus 
of the amygdala. 
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Note Added  in Proof:  Recently, Gnodde and Schuiling 
(Neuroendocrinology,  1976.  20:212-223)  have shown 
that  mecamylamine,  a  cholinergic  nicotinic  receptor 
blocking  agent,  when  injected  intraperitoneally,  de- 
creased  plasma  LH  levels  in  ovariectomized  rats, 
whereas scopolamine, a cholinergic  muscarinic  receptor 
blocking  agent, had no effect on plasma LH levels. 
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